2Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohonnonal, and renal elects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure[J]. J Card Fail, 1998, 4( 1 ):37-44.
3Burner JC Jr. Vasopeptldase inhibition: a new concept in blood pressure management[J].J Hypertens, 1999,17(suppl 1):S37-S43.
5Mc Quillan BM,Picard MH,Leavitt M,et al.Clinical correlatesand reference intervals for pulmonary artery systolic pressure amongechocardiographically normal subjects[J].Circulation,2001,104(23):2797-2802.
6Pesrlman AS,Borer JS,Clark CE,et al.Abnormal right ventricularsize and ventricular septal motion after atrial septal defect closure:etiology andfunctional significance[J].Am J Cardiol,1978,41(2):295-301.
7Wilkens H,Guth A,Konig J,et al.Effect of inhaled iloprost plusoral sildenafil in patients with primary pulmonary hypertension[J].Circulation,2001,104(11):1218-1222.
8Bhat G,Costea A.Reversibility of medically unresponsive pulmona-ry hypertension with nesiritide in a cardiac transplant recipient[J].ASAIO,2003,49(5):608-610.
9Michaels AD,Chatterjee K,De Marco T.Effects of intravenous ne-siritide on pulmonary vascular hemodynamics in pulmonary hyperten-sion[J].Card Fai,2005,1(6):425-431.
